Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Opioid settlement funds news and resources
Related news about the opioid crisis and improving patient outcomes
Texting and other distractions while using smartphones were believed to be part of the cause, as well as drunken, drugged and drowsy driving
In EMS every decision we make is layered with risks and benefits which need to be considered
NYPD posted photos on Twitter of FDNY personnel and a police officer resuscitating a cat
The 32-year-old man struggled with police, who used a stun gun; then went into cardiac arrest
Use this information to engage your field providers about how capnography improves patient care and outcomes
The field training officer is responsible for ensuring new paramedics achieve competency with capnography use and interpretation
The two paramedics said they were acting with the best intentions when they followed the driver
Combating opioid overdose epidemic, the leading cause of accidental death in the U.S., is a top FDA priority
The report calls for changes to the way first responders are equipped to treat overdoses, which are killing 44 people each day in the US
A Resuscitation Outcomes Consortium study comparing two CPR methods of out-of-hospital cardiac arrest found little difference in neurologically intact survival
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.